Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683189 · ClinicalTrials.gov registry record · NA
Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy
A NA study, sponsored by The Cooper Health System.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00683189 is a NA study that has completed, run by The Cooper Health System. The registered enrollment target is 10 participants.
The verdict
NCT00683189, a NA study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Objectives/Purpose: To determine the safety and efficacy of a Vitamin K (Vit K) antagonist (warfarin) in treating Metachromatic Leukodystrophy (MLD).
Interventions
- DRUG Warfarin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683189
The ClinicalTrials.gov registry entry for NCT00683189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Warfarin is the first listed.
NCT00683189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00683189 about?
NCT00683189 is a clinical study titled "Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy". Objectives/Purpose: To determine the safety and efficacy of a Vitamin K (Vit K) antagonist (warfarin) in treating Metachromatic Leukodystrophy (MLD).
What is the current status of trial NCT00683189?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2007-06. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00683189?
The interventions under investigation include: Warfarin (DRUG).
Who is sponsoring clinical trial NCT00683189?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.